Central Nervous System Agents in Medicinal Chemistry (CNSAMC)

Central Nervous System Agents in Medicinal Chemistry is a peer-reviewed international journal dedicated to the discovery, design, and development of therapeutic agents targeting the central nervous system (CNS). The journal integrates principles of medicinal chemistry, pharmacology, neuroscience, and molecular biology to provide a comprehensive understanding of drug action in neurological and psychiatric disorders. It publishes original research articles, review papers, short communications, and clinical trial reports focused on novel CNS-active compounds. Emphasis is placed on rational drug design, structure-activity relationships, molecular mechanisms of action, and preclinical as well as clinical evaluation of neuroactive agents. The journal covers therapeutic strategies for disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, depression, anxiety, and other neurological or psychiatric conditions. In addition to experimental studies, the journal highlights computational modeling, molecular docking, and in silico screening approaches to accelerate CNS drug discovery. By bridging basic research and clinical applications, it provides insights into developing safer and more effective treatments. Central Nervous System Agents in Medicinal Chemistry serves as a vital resource for medicinal chemists, pharmacologists, neuroscientists, and clinicians, promoting interdisciplinary collaboration. Its scope encompasses the full spectrum of CNS drug research, from molecular target identification to clinical translation, thereby contributing to the advancement of innovative therapeutic strategies for neurological and psychiatric diseases worldwide.

Central Nervous System Agents in Medicinal Chemistry (CNSAMC) is :-

• International, Peer-Reviewed, Open Access, Refereed, Medicinal chemistry and drug design of CNS agents, Neurological disorders and therapeutics, Neuroscience and pharmacology, Molecular mechanisms of CNS drug action, Structure‑activity relationships of neuroactive compounds, Preclinical and clinical evaluation of CNS drugs , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1871-5249, E-ISSN: 1875-6166, Established: 2006, Impact Factor: 2.6
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE